Rule 4731-16-20 | Treatment providers in the one-bite program.
(A) Criteria for approval of treatment providers for individuals qualifying for the one-bite program shall include all of the following:
(1) Meet all requirements for treatment providers in rule 4731-16-08 of the Administrative Code.
(2) Medical director is a board-certified addictionologist or board-certified addiction psychiatrist and is experienced in diagnosing and treating physicians and other health care practitioners with substance use disorders;
(a) The medical director shall oversee the initial assessment and diagnosis, ongoing treatment processes, including medications, treatment planning and discharge planning.
(b) The medical director shall have knowledge and experience with prescribing medications specifically indicated for use in patients with substance use disorders and with medications to be avoided for patients with substance use disorders.
(c) The medical director shall have specific training and knowledge regarding the interpretation of the results of toxicology screening for drugs and alcohol.
(3) A board-certified psychiatrist is available to evaluate and provide treatment for co-occurring mental health conditions.
(4) Group therapy is supervised by one of the following masters-level or higher qualifed behavioral healthcare providers:
(a) Board certified addictionologist, board certified addiction psychiatrist, or psychiatrist licensed under Chapter 4731. of the Revised Code;
(b) Licensed independent chemical dependency counselor-clinical supervisor, licensed independent chemical dependency counselor, licensed chemical dependency counselor III, or licensed chemical dependency counselor II licensed under Chapter 4758. of the Revised Code;
(c) Professional clinical counselor, licensed professional counselor, licensed independent social worker, licensed social worker, or marriage and family therapist licensed under Chapter 4757. of the Revised Code;
(d) Advanced practice registered nurse, licensed as a clinical nurse specialist under Chapter 4723. of the Revised Code, who holds certification as a psychiatric mental health clinical nurse specialist issued by the American nurses credentialing center;
(e) Advanced practice registered nurse, licensed as a nurse practitioner under Chapter 4723. of the Revised Code, who holds certification as a psychiatric mental health nurse practitioner issued by the American nurses credentialing center;
(f) Psychologist, as defined in division (A) of section 4732.01 of the Revised Code, licensed under Chapter 4732. of the Revised Code; or
(g) Advanced practice registered nurse licensed under Chapter 4723. of the Revised Code, who holds subspecialty certification as a certified addiction registered nurse-advanced practice issued by the addictions nursing certification board.
(5) Training regarding the eligibility for the one-bite program shall be provided to all staff on a quarterly basis.
(6) Training regarding the boards statutes, rules and policies regarding impairment and reporting violations shall be provided to all staff on a quarterly basis.
(7) The treatment provider shall be capable of completing evaluations pursuant to rule 4731-16-05 of the Administrative Code.
(8) The treatment provider provides abstinence-based education and treatment for all types of substance use disorders.
(9) The treatment provider provides one or more of the following levels of patient care: medical detoxification; inpatient or residential treatment; extended residential treatment; partial hospitalization, intensive outpatient treatment, continuing care or others as necessary.
(10) The treatment provider has the ability to provide extended residential care for patients who require continued treatment of substance use disorders.
(B) The medical director of the treatment provider shall perform an evaluation pursuant to rule 4731-16-05 of the Administrative Code to determine the degree of impairment of the licensee and shall develop an individualized treatment plan. The individualized treatment plan may include a combination of in-patient, residential, partial hospitalization and intensive outpatient treatment.
(1) The treatment provider shall require the licensee to immediately suspend practice upon entering into treatment (upon determination of impairment) and not return to practice for at least thirty days. Clearance from the treatment provider medical director and monitoring organization medical director are required for return to practice.
(2) The treatment provider shall notify the monitoring organization of the determination of impairment and the treatment plan.
(3) The treatment plan shall include, at least once per week, group therapy with other patients who work in similar disciplines as the licensee or other professionals.
(4) The treatment plan shall include education regarding the medical boards statutes, rules and policies with respect to impairment.
(5) The treatment plan shall include education and group therapy to assist the patient to transition back to work.
(C) The treatment provider shall report instances of violations of this chapter to the monitoring organization and the board.
(D) The treatment provider shall complete and maintain records for each licensee seen for evaluation or treatment under the one-bite program in accordance with paragraph (C) of rule 4731-16-07 of the Administrative Code.
(E) Each quarter, the treatment provider shall provide to the monitoring organization and the board the following records regarding licensees seen for evaluation or treatment under the one-bite program:
(1) Number of licensees referred for evaluation (including self-referrals);
(2) Number of licensees evaluated;
(3) Number of licensees determined to be eligible for one-bite program;
(4) Number of referral sources by category (e.g., self-referrals, board referrals, medical society referrals, referrals by colleagues);
(5) Number of licensee evaluations which resulted in treatment recommendations for substance use disorder;
(6) Number of licensees treated based on the treatment providers own recommendations;
(7) Number of licensees treated based on transfer or referral from other treatment providers;
(8) Number of licensees who entered each phase of treatment;
(9) Number of licensees engaged in each phase of treatment;
(10) Number of licensees who successfully completed each phase of treatment;
(11) Number of licensees discharged from each phase of treatment other than upon successful completion, and the rationale for each such discharge;
(12) Number of licensee relapses identified during continuing care and following continuing care;
(13) Number and names of licensees reported to the board under this chapter of the Administrative Code.
(14) Number and identities of referral sources notified of the treatment providers inability to release information under federal law.
(F) The reports provided to the board shall not contain identifying information for the licensee participating in the one-bite program.
Last updated August 31, 2023 at 2:09 PM